Echoiq Limited has released a press release.
US FDA Application Lodged
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Quarterly Report
- Appendix 4C Cash Flow Report
- Management Update
- Completion of US Reader Study
- Receipt of Research & Development Tax Incentive
Later from EchoIQ
- Echo IQ Commences New Heart Failure Clinical Study Using AI
- Investor Presentation
- Validation of EIQ AI at Leading Scientific Conference
- Strategic Integration Partnership Agreement with ScImage Inc
- Groundbreaking study results for Heart Failure AI solution
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ